{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,8,2]],"date-time":"2025-08-02T14:44:03Z","timestamp":1754145843355,"version":"3.41.2"},"reference-count":80,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinical-breast-cancer.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Breast Cancer"],"published-print":{"date-parts":[[2025,8]]},"DOI":"10.1016\/j.clbc.2025.03.017","type":"journal-article","created":{"date-parts":[[2025,4,11]],"date-time":"2025-04-11T04:54:26Z","timestamp":1744347266000},"page":"508-520.e3","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Breast Cancer Clinical Characteristics, Management, and Outcomes in Women Living With HIV\/AIDS Globally: A Systematic Review and Meta-Analysis"],"prefix":"10.1016","volume":"25","author":[{"ORCID":"https:\/\/orcid.org\/0009-0008-7288-6820","authenticated-orcid":false,"given":"Diana","family":"Jaber","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tina","family":"Vaziri","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jennifer","family":"Beckerman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Medhasweta","family":"Sen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuan","family":"Rao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pavani","family":"Chalasani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sharad","family":"Goyal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"8","key":"10.1016\/j.clbc.2025.03.017_bib0001","doi-asserted-by":"crossref","first-page":"e349","DOI":"10.1016\/S2352-3018(17)30066-8","article-title":"Survival of HIV-positive patients starting antiretroviral therapy between 1996 and 2013: a collaborative analysis of cohort studies","volume":"4","year":"2017","journal-title":"Lancet HIV"},{"issue":"9939","key":"10.1016\/j.clbc.2025.03.017_bib0002","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/S0140-6736(14)60604-8","article-title":"Trends in underlying causes of death in people with HIV from 1999 to 2011 (D:A:D): a multicohort collaboration","volume":"384","author":"Smith","year":"2014","journal-title":"Lancet"},{"issue":"9","key":"10.1016\/j.clbc.2025.03.017_bib0003","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1093\/jnci\/djr076","article-title":"Cancer burden in the HIV-infected population in the United States","volume":"103","author":"Shiels","year":"2011","journal-title":"J Natl Cancer Inst"},{"issue":"1","key":"10.1016\/j.clbc.2025.03.017_bib0004","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1097\/QAD.0b013e328317cc2d","article-title":"Trends in the incidence of cancers among HIV-infected persons and the impact of antiretroviral therapy: a 20-year cohort study","volume":"23","author":"Crum-Cianflone","year":"2009","journal-title":"AIDS"},{"issue":"8","key":"10.1016\/j.clbc.2025.03.017_bib0005","doi-asserted-by":"crossref","first-page":"1440","DOI":"10.1093\/cid\/ciac925","article-title":"Age and cancer incidence in 5.2 million people with human immunodeficiency virus (HIV): the South African HIV cancer match study","volume":"76","author":"Ruffieux","year":"2023","journal-title":"Clin Infect Dis"},{"issue":"3","key":"10.1016\/j.clbc.2025.03.017_bib0006","doi-asserted-by":"crossref","first-page":"209","DOI":"10.3322\/caac.21660","article-title":"Global Cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"71","author":"Sung","year":"2021","journal-title":"CA Cancer J Clin"},{"issue":"5","key":"10.1016\/j.clbc.2025.03.017_bib0007","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1097\/QAI.0b013e3181b327ca","article-title":"A meta-analysis of the incidence of non-AIDS cancers in HIV-infected individuals","volume":"52","author":"Shiels","year":"2009","journal-title":"J Acquir Immune Defic Syndr"},{"issue":"9","key":"10.1016\/j.clbc.2025.03.017_bib0008","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1093\/jnci\/djy010","article-title":"Risk of breast, prostate, and colorectal cancer diagnoses among HIV-infected individuals in the United States","volume":"110","author":"Coghill","year":"2018","journal-title":"J Natl Cancer Inst"},{"issue":"11","key":"10.1016\/j.clbc.2025.03.017_bib0009","doi-asserted-by":"crossref","first-page":"2732","DOI":"10.1002\/ijc.31722","article-title":"Breast cancer in women living with HIV: a first global estimate","volume":"143","author":"McCormack","year":"2018","journal-title":"Int J Cancer"},{"key":"10.1016\/j.clbc.2025.03.017_bib0010","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1186\/s13027-019-0245-6","article-title":"Report of clinico-pathological features of breast cancer in HIV-infected and uninfected women in Botswana","volume":"14","author":"Bhatia","year":"2019","journal-title":"Infect Agent Cancer"},{"key":"10.1016\/j.clbc.2025.03.017_bib0011","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1016\/j.jss.2022.04.071","article-title":"Epidemiology of breast cancer presentation in Botswana, South Africa, and the United States","volume":"279","author":"Sinha","year":"2022","journal-title":"J Surg Res"},{"issue":"12","key":"10.1016\/j.clbc.2025.03.017_bib0012","doi-asserted-by":"crossref","first-page":"2261","DOI":"10.1089\/jwh.2010.2026","article-title":"Breast cancer in women with human immunodeficiency virus infection: pathological, clinical, and prognostic implications","volume":"19","author":"Sarhan","year":"2010","journal-title":"J Womens Health (Larchmt)"},{"issue":"4","key":"10.1016\/j.clbc.2025.03.017_bib0013","first-page":"393","article-title":"Outcomes and prognostic factors for women with breast cancer in Malawi","volume":"31","author":"Youngblood","year":"2020","journal-title":"Cancer Causes Control"},{"issue":"3","key":"10.1016\/j.clbc.2025.03.017_bib0014","doi-asserted-by":"crossref","first-page":"e160","DOI":"10.1016\/S2352-3018(21)00326-X","article-title":"Disparities in breast cancer survival between women with and without HIV across sub-Saharan Africa (ABC-DO): a prospective, cohort study","volume":"9","author":"Chasimpha","year":"2022","journal-title":"Lancet HIV"},{"key":"10.1016\/j.clbc.2025.03.017_bib0015","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.breast.2021.05.014","article-title":"Survival of south african women with breast cancer receiving anti-retroviral therapy for HIV","volume":"59","author":"Phakathi","year":"2021","journal-title":"Breast"},{"issue":"1","key":"10.1016\/j.clbc.2025.03.017_bib0016","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1007\/s10549-021-06265-w","article-title":"Impact of HIV infection on overall survival among women with stage IV breast cancer in South Africa","volume":"189","author":"Pumpalova","year":"2021","journal-title":"Breast Cancer Res Treat"},{"issue":"3","key":"10.1016\/j.clbc.2025.03.017_bib0017","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1007\/s10549-023-06969-1","article-title":"PAM50 intrinsic subtypes, risk of recurrence score and breast cancer survival in HIV-positive and HIV-negative patients-a South African cohort study","volume":"200","author":"Phakathi","year":"2023","journal-title":"Breast Cancer Res Treat"},{"issue":"4","key":"10.1016\/j.clbc.2025.03.017_bib0018","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1097\/QAD.0000000000002810","article-title":"Impact of HIV infection on baseline characteristics and survival of women with breast cancer","volume":"35","author":"Brand\u00e3o","year":"2021","journal-title":"AIDS"},{"issue":"2","key":"10.1016\/j.clbc.2025.03.017_bib0019","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1002\/ijc.33981","article-title":"Impact of HIV infection on survival among women with stage I-III breast cancer: results from the South African breast cancer and HIV outcomes study","volume":"151","author":"Ayeni","year":"2022","journal-title":"Int J Cancer"},{"key":"10.1016\/j.clbc.2025.03.017_bib0020","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/j.breast.2022.08.001","article-title":"Survival in HIV+ and HIV- women with breast cancer treated at the National Cancer Institute in the city of Rio de Janeiro, Brazil, between 2000 and 2014","volume":"65","author":"Ferreira","year":"2022","journal-title":"Breast"},{"key":"10.1016\/j.clbc.2025.03.017_bib0021","article-title":"Relative dose intensity and pathologic response rates in patients with breast cancer and with and without HIV who received neoadjuvant chemotherapy","volume":"8","author":"Martei","year":"2022","journal-title":"JCO Glob Oncol"},{"issue":"2","key":"10.1016\/j.clbc.2025.03.017_bib0022","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1089\/aid.2019.0145","article-title":"Short communication: differences in 5-year survival after cancer diagnosis between HIV clinic enrollees and the general U.S. Population","volume":"36","author":"Calkins","year":"2020","journal-title":"AIDS Res Hum Retroviruses"},{"issue":"1","key":"10.1016\/j.clbc.2025.03.017_bib0023","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1002\/jso.20171","article-title":"Breast cancer in women with HIV\/AIDS: report of five cases with a review of the literature","volume":"89","author":"Oluwole","year":"2005","journal-title":"J. Surg. Oncol."},{"issue":"18","key":"10.1016\/j.clbc.2025.03.017_bib0024","doi-asserted-by":"crossref","first-page":"2933","DOI":"10.1097\/01.aids.0000433236.55937.cb","article-title":"Contribution of HIV infection to mortality among cancer patients in Uganda","volume":"27","author":"Coghill","year":"2013","journal-title":"AIDS"},{"issue":"12","key":"10.1016\/j.clbc.2025.03.017_bib0025","article-title":"Time to cancer treatment and chemotherapy relative dose intensity for patients with breast cancer living with HIV","volume":"6","author":"O'Neil","year":"2023","journal-title":"JAMA Netw Open"},{"key":"10.1016\/j.clbc.2025.03.017_bib0026","article-title":"The PRISMA 2020 statement: an updated guideline for reporting systematic reviews","volume":"372","author":"Page","year":"2021","journal-title":"BMJ"},{"year":"2012","series-title":"Validity and Inter-Rater Reliability Testing of Quality Assessment Instruments","author":"Hartling","key":"10.1016\/j.clbc.2025.03.017_bib0027"},{"key":"10.1016\/j.clbc.2025.03.017_bib0028","series-title":": StatPearls [Internet]","article-title":"Breast cancer","author":"Menon","year":"2024"},{"key":"10.1016\/j.clbc.2025.03.017_bib0029","article-title":"Choosing effect measures and computing estimates of effect","author":"Higgins","year":"2022","journal-title":"Cochrane Handbook for Systematic Reviews of Interventions. Version 6.3"},{"issue":"3","key":"10.1016\/j.clbc.2025.03.017_bib0030","doi-asserted-by":"crossref","first-page":"215","DOI":"10.3816\/CBC.2001.n.024","article-title":"Breast cancer and human immunodeficiency virus: a report of 20 cases","volume":"2","author":"Hurley","year":"2001","journal-title":"Clin Breast Cancer"},{"issue":"2","key":"10.1016\/j.clbc.2025.03.017_bib0031","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1023\/A:1020587504186","article-title":"Breast cancer in women with human immunodeficiency virus infection: implications for diagnosis and therapy","volume":"76","author":"El-Rayes","year":"2002","journal-title":"Breast Cancer Res Treat"},{"issue":"1","key":"10.1016\/j.clbc.2025.03.017_bib0032","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1177\/1545109710385002","article-title":"Breast cancer in HIV-infected patients: A retrospective single-institution study","volume":"10","author":"Ruiz","year":"2011","journal-title":"J Int Assoc Physicians AIDS Care (Chic)"},{"issue":"18","key":"10.1016\/j.clbc.2025.03.017_bib0033","doi-asserted-by":"crossref","first-page":"3335","DOI":"10.1016\/j.ejca.2012.05.019","article-title":"Breast cancer among HIV infected individuals from the ONCOVIH study, in France: therapeutic implications","volume":"48","author":"Spano","year":"2012","journal-title":"Eur J Cancer"},{"issue":"2","key":"10.1016\/j.clbc.2025.03.017_bib0034","doi-asserted-by":"crossref","first-page":"e53","DOI":"10.1016\/j.clbc.2013.11.002","article-title":"Outcomes and chemotherapy-related toxicity in HIV-infected patients with breast cancer","volume":"14","author":"Singh","year":"2014","journal-title":"Clin Breast Cancer"},{"issue":"3","key":"10.1016\/j.clbc.2025.03.017_bib0035","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1007\/s10549-015-3275-9","article-title":"Clinical outcomes in breast cancer patients with HIV\/AIDS: a retrospective study","volume":"149","author":"Gomez","year":"2015","journal-title":"Breast Cancer Res Treat"},{"issue":"9","key":"10.1016\/j.clbc.2025.03.017_bib0036","doi-asserted-by":"crossref","first-page":"e4552","DOI":"10.1097\/GOX.0000000000004552","article-title":"Postoperative outcomes following a multidisciplinary approach to HIV-positive breast cancer patients","volume":"10","author":"Sayyed","year":"2022","journal-title":"Plast Reconstr Surg Glob Open"},{"issue":"4","key":"10.1016\/j.clbc.2025.03.017_bib0037","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1016\/S1413-8670(11)70211-2","article-title":"Breast cancer in a cohort of human immunodeficiency virus (HIV)-infected women from Rio de Janeiro, Brazil: a cases series report and an incidence rate estimate","volume":"15","author":"Andrade","year":"2011","journal-title":"Braz J Infect Dis"},{"issue":"1","key":"10.1016\/j.clbc.2025.03.017_bib0038","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1002\/ijc.34671","article-title":"Age at diagnosis for lung, colon, breast and prostate cancers: an international comparative study","volume":"154","author":"Zahed","year":"2024","journal-title":"Int J Cancer"},{"key":"10.1016\/j.clbc.2025.03.017_bib0039","unstructured":"UNAIDS. The path that ends AIDS: UNAIDS report 2023. Published 2023. Accessed August 26, 2024. Available from: https:\/\/thepath.unaids.org\/wp-content\/themes\/unaids2023\/assets\/files\/2023_report.pdf."},{"key":"10.1016\/j.clbc.2025.03.017_bib0040","series-title":"Conference on Retroviruses and Opportunistic Infections; March 4, 2019; Seattle, Washington","article-title":"HIV is associated with decreased breast cancer survival: a prospective cohort study","author":"Sadigh","year":"2024"},{"issue":"5","key":"10.1016\/j.clbc.2025.03.017_bib0041","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1200\/JGO.2015.002451","article-title":"Phenotype and treatment of breast cancer in HIV-positive and -negative women in Cape Town, South Africa","volume":"2","author":"Langenhoven","year":"2016","journal-title":"J Glob Oncol"},{"issue":"5","key":"10.1016\/j.clbc.2025.03.017_bib0042","doi-asserted-by":"crossref","DOI":"10.1136\/esmoopen-2020-000829","article-title":"Breast cancer subtypes: implications for the treatment and survival of patients in Africa-a prospective cohort study from Mozambique","volume":"5","author":"Brand\u00e3o","year":"2020","journal-title":"ESMO Open"},{"key":"10.1016\/j.clbc.2025.03.017_bib0043","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1016\/j.canep.2017.12.007","article-title":"Breast cancer survival in Soweto, Johannesburg, South Africa: a receptor-defined cohort of women diagnosed from 2009 to 11","volume":"52","author":"Cubasch","year":"2018","journal-title":"Cancer Epidemiol"},{"issue":"16","key":"10.1016\/j.clbc.2025.03.017_bib0044","doi-asserted-by":"crossref","first-page":"2868","DOI":"10.1002\/cncr.32158","article-title":"Advanced stage at diagnosis and elevated mortality among US patients with cancer infected with HIV in the National Cancer Data Base","volume":"125","author":"Coghill","year":"2019","journal-title":"Cancer"},{"issue":"12","key":"10.1016\/j.clbc.2025.03.017_bib0045","doi-asserted-by":"crossref","first-page":"2063","DOI":"10.1002\/cncr.29324","article-title":"Cancer stage at diagnosis in patients infected with the human immunodeficiency virus and transplant recipients","volume":"121","author":"Shiels","year":"2015","journal-title":"Cancer"},{"issue":"6","key":"10.1016\/j.clbc.2025.03.017_bib0046","doi-asserted-by":"crossref","first-page":"524","DOI":"10.3322\/caac.21754","article-title":"Breast cancer statistics, 2022","volume":"72","author":"Giaquinto","year":"2022","journal-title":"CA Cancer J Clin"},{"key":"10.1016\/j.clbc.2025.03.017_bib0047","doi-asserted-by":"crossref","DOI":"10.1155\/2012\/915610","article-title":"Epidemiology of breast cancer in Europe and Africa","volume":"2012","author":"Abdulrahman","year":"2012","journal-title":"J Cancer Epidemiol"},{"issue":"12","key":"10.1016\/j.clbc.2025.03.017_bib0048","doi-asserted-by":"crossref","first-page":"e923","DOI":"10.1016\/S2214-109X(16)30259-5","article-title":"Stage at diagnosis of breast cancer in sub-Saharan Africa: a systematic review and meta-analysis","volume":"4","author":"Jedy-Agba","year":"2016","journal-title":"Lancet Glob Health"},{"issue":"2","key":"10.1016\/j.clbc.2025.03.017_bib0049","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0171024","article-title":"Barriers to early presentation and diagnosis of breast cancer among African women living in sub-Saharan Africa","volume":"12","author":"Akuoko","year":"2017","journal-title":"PLoS One"},{"issue":"2","key":"10.1016\/j.clbc.2025.03.017_bib0050","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0192071","article-title":"Barriers to early presentation of breast cancer among women in Soweto, South Africa","volume":"13","author":"Joffe","year":"2018","journal-title":"PLoS One"},{"issue":"9","key":"10.1016\/j.clbc.2025.03.017_bib0051","doi-asserted-by":"crossref","first-page":"2173","DOI":"10.1002\/ijc.28861","article-title":"Stage at breast cancer diagnosis and distance from diagnostic hospital in a periurban setting: a South African public hospital case series of over 1,000 women","volume":"135","author":"Dickens","year":"2014","journal-title":"Int J Cancer"},{"issue":"2.2","key":"10.1016\/j.clbc.2025.03.017_bib0052","first-page":"1","article-title":"Factors contributing to late presentation of breast cancer in Africa: A systematic literature review","volume":"8","author":"Donkor","year":"2015","journal-title":"Arch Med"},{"issue":"1","key":"10.1016\/j.clbc.2025.03.017_bib0053","doi-asserted-by":"crossref","first-page":"1601","DOI":"10.1186\/s12913-022-08927-x","article-title":"Health system barriers influencing timely breast cancer diagnosis and treatment among women in low and middle-income Asian countries: evidence from a mixed-methods systematic review","volume":"22","author":"Afaya","year":"2022","journal-title":"BMC Health Serv Res"},{"issue":"3","key":"10.1016\/j.clbc.2025.03.017_bib0054","doi-asserted-by":"crossref","first-page":"E673","DOI":"10.9778\/cmajo.20170038","article-title":"A cross-sectional population-based study of breast cancer screening among women with HIV in Ontario, Canada","volume":"5","author":"Kendall","year":"2017","journal-title":"CMAJ Open"},{"issue":"1","key":"10.1016\/j.clbc.2025.03.017_bib0055","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1080\/09540121.2013.802276","article-title":"Preventive cancer screening practices in HIV-positive patients","volume":"26","author":"Momplaisir","year":"2014","journal-title":"AIDS Care"},{"key":"10.1016\/j.clbc.2025.03.017_bib0056","article-title":"Qualitative factors influencing breast and cervical cancer screening in women: A scoping review","volume":"27","author":"Lau","year":"2022","journal-title":"Prev Med Rep"},{"issue":"12","key":"10.1016\/j.clbc.2025.03.017_bib0057","doi-asserted-by":"crossref","first-page":"e1993","DOI":"10.1016\/S2214-109X(24)00376-0","article-title":"The association of HIV status with triple-negative breast cancer in patients with breast cancer in South Africa: a cross-sectional analysis of case-only data from a prospective cohort study","volume":"12","author":"Dubner","year":"2024","journal-title":"Lancet Glob Health"},{"issue":"2","key":"10.1016\/j.clbc.2025.03.017_bib0058","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1089\/jwh.2021.0276","article-title":"The association between HIV status, estradiol, and sex hormone binding globulin among premenopausal women in the women's interagency HIV study","volume":"31","author":"Coburn","year":"2022","journal-title":"J Womens Health (Larchmt)"},{"issue":"4","key":"10.1016\/j.clbc.2025.03.017_bib0059","doi-asserted-by":"crossref","first-page":"E610","DOI":"10.1210\/jc.2012-3195","article-title":"Gonadotropin and sex steroid levels in HIV-infected premenopausal women and their association with subclinical atherosclerosis in HIV-infected and -uninfected women in the women's interagency HIV study (WIHS)","volume":"98","author":"Karim","year":"2013","journal-title":"J Clin Endocrinol Metab"},{"issue":"6","key":"10.1016\/j.clbc.2025.03.017_bib0060","doi-asserted-by":"crossref","first-page":"1645","DOI":"10.1016\/j.fertnstert.2007.01.122","article-title":"Biologic markers of ovarian reserve and reproductive aging: application in a cohort study of HIV infection in women","volume":"88","author":"Seifer","year":"2007","journal-title":"Fertil Steril"},{"issue":"3","key":"10.1016\/j.clbc.2025.03.017_bib0061","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1097\/QAD.0000000000002084","article-title":"HIV and amenorrhea: a meta-analysis","volume":"33","author":"King","year":"2019","journal-title":"AIDS"},{"issue":"6","key":"10.1016\/j.clbc.2025.03.017_bib0062","doi-asserted-by":"crossref","first-page":"765.e1","DOI":"10.1016\/j.ajog.2014.12.040","article-title":"Predictors of early menopause in HIV-infected women: a prospective cohort study","volume":"212","author":"Calvet","year":"2015","journal-title":"Am J Obstet Gynecol"},{"issue":"10","key":"10.1016\/j.clbc.2025.03.017_bib0063","doi-asserted-by":"crossref","first-page":"1517","DOI":"10.1086\/497270","article-title":"HIV infection, drug use, and onset of natural menopause","volume":"41","author":"Schoenbaum","year":"2005","journal-title":"Clin Infect Dis"},{"issue":"3","key":"10.1016\/j.clbc.2025.03.017_bib0064","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1097\/QAI.0b013e318162f597","article-title":"Longitudinal anthropometric patterns among HIV-infected and HIV-uninfected women","volume":"47","author":"Justman","year":"2008","journal-title":"J Acquir Immune Defic Syndr"},{"issue":"8","key":"10.1016\/j.clbc.2025.03.017_bib0065","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1089\/aid.2019.0278","article-title":"Endogenous hormones and antiretroviral exposure in plasma, cervicovaginal fluid, and upper-layer packed cells of Malawian women living with HIV","volume":"36","author":"Nicol","year":"2020","journal-title":"AIDS Res Hum Retroviruses"},{"issue":"3","key":"10.1016\/j.clbc.2025.03.017_bib0066","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1093\/cid\/cix772","article-title":"Estradiol levels are altered in human immunodeficiency virus-infected pregnant women randomized to Efavirenz-versus Lopinavir\/Ritonavir-based antiretroviral therapy","volume":"66","author":"McDonald","year":"2018","journal-title":"Clin Infect Dis"},{"issue":"3","key":"10.1016\/j.clbc.2025.03.017_bib0067","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1093\/cid\/cix761","article-title":"Elevated levels of estradiol in human immunodeficiency virus-infected pregnant women on protease inhibitor-based regimens","volume":"66","author":"Balogun","year":"2018","journal-title":"Clin Infect Dis"},{"issue":"12","key":"10.1016\/j.clbc.2025.03.017_bib0068","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0014349","article-title":"HIV tropism and decreased risk of breast cancer","volume":"5","author":"Hessol","year":"2010","journal-title":"PLoS One"},{"issue":"1","key":"10.1016\/j.clbc.2025.03.017_bib0069","doi-asserted-by":"crossref","first-page":"34","DOI":"10.2174\/157016208783571991","article-title":"Human immunodeficiency virus-induced apoptosis of human breast cancer cells via CXCR4 is mediated by the viral envelope protein but does not require CD4","volume":"6","author":"Endo","year":"2008","journal-title":"Curr HIV Res"},{"issue":"2","key":"10.1016\/j.clbc.2025.03.017_bib0070","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1007\/s10549-008-0186-z","article-title":"Post-transcriptional regulation of chemokine receptor CXCR4 by estrogen in HER2 overexpressing, estrogen receptor-positive breast cancer cells","volume":"117","author":"Sengupta","year":"2009","journal-title":"Breast Cancer Res Treat"},{"key":"10.1016\/j.clbc.2025.03.017_bib0071","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/j.ijsu.2016.08.520","article-title":"The effect of HIV infection on the surgical, chemo- and radiotherapy management of breast cancer. A prospective cohort study","volume":"34","author":"Phakathi","year":"2016","journal-title":"Int J Surg"},{"issue":"7","key":"10.1016\/j.clbc.2025.03.017_bib0072","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1089\/apc.2013.0370","article-title":"Tolerability of chemotherapy in HIV-infected women with breast cancer: are there prognostic implications?","volume":"28","author":"Parameswaran","year":"2014","journal-title":"AIDS Patient Care STDS"},{"key":"10.1016\/j.clbc.2025.03.017_bib0073","unstructured":"National Comprehensive Cancer Network. Cancer in people with HIV. (Version 2.2024). https:\/\/www.nccn.org\/professionals\/physician_gls\/pdf\/hiv.pdf. Accessed August 10, 2024."},{"issue":"3","key":"10.1016\/j.clbc.2025.03.017_bib0074","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1007\/s10549-020-05889-8","article-title":"A comparison of complete pathologic response rates following neoadjuvant chemotherapy among South African breast cancer patients with and without concurrent HIV infection","volume":"184","author":"Nietz","year":"2020","journal-title":"Breast Cancer Res Treat"},{"issue":"2","key":"10.1016\/j.clbc.2025.03.017_bib0075","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1001\/jamaoncol.2019.4648","article-title":"Immune status and associated mortality after cancer treatment among individuals with HIV in the antiretroviral therapy era","volume":"6","author":"Calkins","year":"2020","journal-title":"JAMA Oncol"},{"issue":"1","key":"10.1016\/j.clbc.2025.03.017_bib0076","doi-asserted-by":"crossref","DOI":"10.1093\/jnci\/djw192","article-title":"Relevance of tumor-infiltrating immune cell composition and functionality for disease outcome in breast cancer","volume":"109","author":"Bense","year":"2016","journal-title":"J Natl Cancer Inst"},{"issue":"13","key":"10.1016\/j.clbc.2025.03.017_bib0077","doi-asserted-by":"crossref","first-page":"1135","DOI":"10.1001\/jama.2024.3056","article-title":"Tumor-infiltrating lymphocytes in triple-negative breast cancer","volume":"331","author":"Leon-Ferre","year":"2024","journal-title":"JAMA"},{"key":"10.1016\/j.clbc.2025.03.017_bib0078","doi-asserted-by":"crossref","DOI":"10.1016\/j.eclinm.2019.11.001","article-title":"Association between HIV infection and outcomes of care among medicare enrollees with breast cancer","volume":"17","author":"Chhatre","year":"2019","journal-title":"EClinicalMedicine"},{"issue":"21","key":"10.1016\/j.clbc.2025.03.017_bib0079","doi-asserted-by":"crossref","first-page":"2376","DOI":"10.1200\/JCO.2014.59.5967","article-title":"Elevated cancer-specific mortality among HIV-infected patients in the United States","volume":"33","author":"Coghill","year":"2015","journal-title":"J Clin Oncol"},{"issue":"15","key":"10.1016\/j.clbc.2025.03.017_bib0080","doi-asserted-by":"crossref","first-page":"2399","DOI":"10.1002\/cncr.30052","article-title":"Disparities in cancer treatment among patients infected with the human immunodeficiency virus","volume":"122","author":"Suneja","year":"2016","journal-title":"Cancer"}],"container-title":["Clinical Breast Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1526820925000862?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1526820925000862?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,7,17]],"date-time":"2025-07-17T15:16:42Z","timestamp":1752765402000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1526820925000862"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8]]},"references-count":80,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2025,8]]}},"alternative-id":["S1526820925000862"],"URL":"https:\/\/doi.org\/10.1016\/j.clbc.2025.03.017","relation":{},"ISSN":["1526-8209"],"issn-type":[{"type":"print","value":"1526-8209"}],"subject":[],"published":{"date-parts":[[2025,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Breast Cancer Clinical Characteristics, Management, and Outcomes in Women Living With HIV\/AIDS Globally: A Systematic Review and Meta-Analysis","name":"articletitle","label":"Article Title"},{"value":"Clinical Breast Cancer","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clbc.2025.03.017","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}